Lisinopril Impurity 12 | CAS 130414-30-1 - Request Quote
Lisinopril Impurity 12
| SZ CAT No: | SZ-L027035 |
| CAS No | 130414-30-1 |
| Mol.F. | C20H27F3N2O5 |
| Mol.Wt. | 432.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lisinopril Impurity 12 is chemically N2-((R)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)-N6-(2,2,2-trifluoroacetyl)-L-lysine. Lisinopril Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Lisinopril Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lisinopril.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 130414-30-1
Purchase 130414-30-1
Order 130414-30-1
Enquire 130414-30-1
price of 130414-30-1
130414-30-1 Supplier
130414-30-1 Manufacturer
130414-30-1 Exporter
buy high quality Lisinopril Impurity 12
Purchase Lisinopril Impurity 12
Lisinopril Impurity 12 suppliers
Lisinopril Impurity 12 manufacturers
Lisinopril Impurity 12 price
Order Lisinopril Impurity 12
Enquire Lisinopril Impurity 12
Lisinopril Impurity 12 cost
Lisinopril Impurity 12 Supplier
Lisinopril Impurity 12 Distributor
Lisinopril Impurity 12 for Method Validation
Lisinopril Reference Standard
Lisinopril Impurity 12 for ANDA Filing
Lisinopril Impurity 12 for Forced Degradation Studies
Lisinopril Impurity 12 Identification Standards
Lisinopril Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


